About OneOme

OneOme, co-founded by Mayo Clinic, is working to deliver the most comprehensive, cost-effective pharmacogenomic testing and tools for all providers across the globe to use in everyday patient care. By increasing adoption of pharmacogenomics, OneOme may help providers make better prescription decisions, protect patients from adverse drug reactions and drug ineffectiveness, and reduce healthcare costs.

Company news

OneOme Receives License to Offer its Comprehensive Pharmacogenomic Test in New York State


MINNEAPOLIS (December 5, 2018) – OneOme, co-developed by Mayo Clinic, today announced that it has received approval from New York State Department of Health to perform its pharmacogenomic testing for patients residing in the state.


OneOme and St. Catherine Specialty Hospital in Croatia Partner to Increase Access to Pharmacogenetic Testing in Europe


MINNEAPOLIS and ZAGREB, Croatia (October 15, 2018) - OneOme, co-founded with Mayo Clinic, announced today that they are partnering with St. Catherine Specialty Hospital, a European Center of Excellence, to bring innovative, actionable pharmacogenetic (PGx) testing to patients.


OneOme Expands its Comprehensive Pharmacogenomic Test Offering with New Genes and Medications


MINNEAPOLIS (MAY 22, 2018) — OneOme, co-developed by Mayo Clinic, today announced several significant enhancements to its product offering, including the addition of four new genes (HLA-A, HLA-B, CYP4F2, and CYP2C Cluster) and nine new medications ...


OneOme Named One of the World’s 50 Most Innovative Companies for 2018 by Fast Company


MINNEAPOLIS (February 20, 2018) – OneOme, a healthcare technology company whose genetic test helps predict how a person will respond to hundreds of medications and enables healthcare providers to prescribe more effective medications, today announced that it is included in Fast Company’s annual ranking of the 50 Most Innovative Companies for 2018.


Investment opportunities

If you are interested in being a part of the future of precision medicine and would like to discuss investment opportunities with OneOme, please contact us at

People of OneOme

Leadership Toggle icon

  • Paul Owen


    Paul joined OneOme as its President and COO in August 2015 and became CEO in June of 2016. Prior to OneOme, Paul led global commercialization for Invitae, a San Francisco-based hereditary disease diagnostics company that is listed on the New York Stock Exchange and that raised over $120Million in capital during Paul’s tenure. Prior to Invitae, Paul served as Vice Chair of Global Business Development for Mayo Clinic and was the leader of Mayo Medical Laboratories’ global commercial team – one of the world’s largest full-service reference labs. Prior to that, Paul held leadership roles at what is now Zimmer-Biomet and at Boston Scientific, both highly competitive, cutting-edge, and fast-paced organizations. Paul received his B.S. in business administration from the University of Wisconsin – Stout.

  • Jason Ross


    Jason is the Chief Technology Officer with over 20 years of Healthcare Information Technology experience. Prior to joining OneOme, Jason held the position of IT Section Head at Mayo Clinic and was responsible for leading their IT strategy for genomics, informatics and advanced analytics. In addition, he was the Associate Director of IT for Mayo Clinic’s Center for Individualized Medicine. Jason holds a B.S. in molecular biology from University of Wisconsin – Eau Claire and a M.A. in Healthcare Administration from St. Mary’s University of Minnesota.

  • Brian Arendt


    Brian joined OneOme as the Director of Commercial Operations in October 2015. Previously, he held management roles in operations, analytics, and IT for a genetic information company, diagnostic reference laboratory, and an integrated health system. Brian has a B.S. in marketing from Winona State University and an M.B.A. from the University of Wisconsin — La Crosse.

  • Bronwyn Hartung


    Bronwyn is the founder of Phoenix Laboratory Consulting, based in Prospect, Kentucky. She has 15 years of experience in molecular genetics, with expertise in the design and validation of laboratory-developed tests, high-complexity clinical laboratory operations, quality systems, regulatory compliance, and medical device software. Her pharmacogenetics specialties include CYP450 haplotype and copy number analysis, data interpretation, and reporting. She earned her B.S. in Biology at Trinity University and her Ph.D. at Indiana University, followed by a postdoctoral fellowship in microbial pathology at the University of Iowa.

  • Clayton Weiby

    Clayton Weiby — Senior Director of Finance

    Clayton leads the finance and accounting function for OneOme. He is an experienced business leader with 20+ years of experience in finance, accounting, business development, training, and trading. Clayton received his MBA in Finance from the University of Minnesota's Carlson School of Business and his undergraduate degree in Accounting and Spanish from the University of St. Thomas.

  • Don Skifter


    Don joined the OneOme team in May of 2016 as Director of East Sales and after making significant progress advancing OneOme's commercial efforts was subsequently promoted to Vice President of North American Sales and Business Development. Don has spent the past 15 years of his career in various commercial roles within genetic technology and services sectors including roles most recently at the Broad Institute where he helped launch Broad Genomic Services and at Complete Genomics, Sequenom, and Invitrogen/Life Technologies/Thermo Fisher prior to that. Don received his PhD in pharmacology and neuroscience from the University of Nebraska Medical Center and his MBA from the University of Nebraska Omaha.

  • Jason Sheard


    Jason is the Director of Product Development at OneOme. He is a technical leader with diverse product development experience, outstanding customer and engineering management skills, and a proven ability to build consensus and motivate teams to excel. Previously, he was the Vice President of Products for Logic PD, and before that he was Director of Electrical Engineering. Jason has a B.S. in physics from Bethel University and an M.S. in mechanical engineering from the University of Minnesota — Twin Cities.

  • Kesah Scmitt


    Kesah joined OneOme in 2016 and is the Director of Marketing. She has over ten years experience helping companies launch and grow their businesses. With a background in marketing, product development, and healthcare innovation, Kesah has worked with organizations like Mayo Clinic and Boston Scientific to develop and execute marketing strategies. Kesah received her B.A from Tulane University.

  • Mark Billmayer


    Mark leads pharmacogenomics program development for OneOme, focusing on plan sponsors and PBMs. He has worked in many facets of healthcare including health plans, hospitals and clinics, PBMs, pharmacies, consulting and marketing firms, and technology startups. Most recently, Mark served as Director of Product Development within Specialty Pharmacy for OptumRx. Previously, with Intellogy Health Designs, he consulted on a wide variety of projects with US Oncology, Teradata, Fujitsu, McKesson/Relay Health, Rocky Mountain Cancer Centers and more. Mark received his B.S. in health and medical marketing from the University Wisconsin-Superior.

  • Stephen Floe


    Stephen leads strategic partner initiatives at OneOme. Prior to OneOme, he led corporate strategy for a novel in-vitro diagnostic company, including its financing and triple aim focus. His healthcare finance background includes Bank of America Merrill Lynch, where he supported leading medical companies, evaluating and advancing opportunities for new technologies. His experience includes facilitating collaboration in healthcare across continents; he has traveled extensively in Asia. Steve received his B.A. in Business & Economics from Wheaton College in Illinois. He is passionate about value-based healthcare.

Board Members

  • Troy Kopischke


    Troy is the co-founder and chairman of the board of OneOme. He is also a co-CEO, co-founder, and managing partner of Invenshure. Previously, he was the President and Chief Financial Officer at Steady State Imaging, where he was instrumental in developing a commercialization strategy that helped guide the sale of the company to GE Healthcare in 2011. Troy holds a B.S. in electrical engineering from the University of Minnesota as well as a B.A. in physics and a B.A. in engineering science from Bethel College.

  • Paul Owen


    Paul joined OneOme as its President and COO in August 2015 and became CEO in June of 2016. Prior to OneOme, Paul led global commercialization for Invitae, a San Francisco-based hereditary disease diagnostics company that is listed on the New York Stock Exchange and that raised over $120Million in capital during Paul’s tenure. Prior to Invitae, Paul served as Vice Chair of Global Business Development for Mayo Clinic and was the leader of Mayo Medical Laboratories’ global commercial team – one of the world’s largest full-service reference labs. Prior to that, Paul held leadership roles at what is now Zimmer-Biomet and at Boston Scientific, both highly competitive, cutting-edge, and fast-paced organizations. Paul received his B.S. in business administration from the University of Wisconsin – Stout.

  • Jeremy Friese

    Jeremy Friese, M.D., MBA

    Jeremy is a “recovering Mayo physician” turned entrepreneur and director. He is founder and CEO at Verata Health, an Insurtech company using artificial intelligence to create frictionless prior authorization between healthcare providers and payers. He is also founder and director of Ostra, a cybersecurity company focused on small and medium businesses. Previously, Jeremy was an interventional radiologist at Mayo Clinic with numerous departmental and institutional leadership responsibilities. Jeremy earned his MD at Mayo Clinic and completed surgery and radiology training at Mayo Clinic and Harvard Medical School. He earned his MBA at Harvard Business School.

  • Danny Cunagin


    Danny Cunagin is Co-CEO of Invenshure, a venture catalyst that identifies, incubates, funds and grows emerging technology companies ready for commercialization. He is acting CEO of Invenshure’s portfolio companies in medical imaging and biotechnology and previously was the Chief Executive Officer and Chairman of the Board of Steady State Imaging and was CEO, Chairman, and majority owner of Logic Product Development. He was noted as one of “forty under 40” in 1999 by City Business, and has a B.S.M.E. from the University of Kentucky.


  • John Black


    John L. Black III, M.D. is one of the co-founders of OneOme and also a consultant in the Division of Clinical Biochemistry and Immunology with a joint appointment in the Department of Psychiatry and Psychology at Mayo Clinic in Rochester. He joined the staff of Mayo Clinic in 1985 and is currently the co-director of the Personalized Genomics Laboratory. He received his B.A. and M.S. in psychology from the University of Wyoming. He received his M.D. (cum laude) from Creighton University School of Medicine. He is board certified in general, geriatric, and addiction psychiatry and is a clinical chemist.

  • Liewei Wang

    LIEWEI WANG, M.D., Ph.D. — MAYO CLINIC, Co-founder OneOme

    Dr. Wang is a professor in the Department of Molecular Pharmacology and Experimental Therapeutics (MPET) at Mayo Clinic Rochester. Her research involves the application of high-throughput "omics" technologies to identify biomarkers that might help us individualize cancer therapies, understand mechanisms of drug action, and facilitate target identification and drug development. She is also a co-leader of the Mayo Pharmacogenomics Program within the Mayo CIM, where many of the projects involving personalized medicine have been conducted. She is the co-PI for the Mayo-NIH clinical pharmacology T32 training grant and the Associate Director for the Mayo MPET graduate program.

  • Richard Weinshilboum


    Dr. Weinshilboum received B.A. and M.D. degrees from the University of Kansas, followed by residency training in internal medicine at the Massachusetts General Hospital. He was also a pharmacology Research Associate at the National Institutes of Health (NIH). He began his affiliation with the Mayo Medical School and Mayo Clinic in 1972, where he is presently Professor of Pharmacology and Medicine and Mary Lou and John H. Dasburg Professor of Cancer Genomics Research. He currently directs the Pharmacogenomics Program of the Mayo Center for Individualized Medicine and is co-Principal Investigator of the long-standing US NIH Pharmacogenomics Research Network Center at the Mayo Clinic.

  • Bennett Clark, MD - Medical Advisor

    Bennett Clark, MD - Medical Advisor

    Dr. Bennett Clark is a hospitalist and Assistant Professor at the University of Minnesota. He earned his medical degree from Stanford and completed his residency training in the Osler Program at Johns Hopkins Hospital, where he went on to serve as Assistant Chief of Service for the Barker Firm. His current research focuses on medical decision making, while earlier work, carried out in collaboration with the American Medical Association’s Office of Medical Ethics, investigated ethical issues surrounding genetic testing.

  • Carmen Kosicek, MSN, PMHNP - Advisory Board Member

    Carmen Kosicek, MSN, PMHNP - Advisory Board Member

    Carmen Kosicek, RN, MSN is the CEO & founder of Alay Health Team, a psychiatric clinic caring for children and adults both on-site and via telemedicine. She is also the clinical medical director at Dodge County Bridges, a nonprofit committed to providing supervised residential and support services to adult clients transitioning from rehabilitation to recovery from substance abuse. Carmen’s healthcare career has spanned clinical positions in nuclear medicine, labor and delivery BSN-RN in women’s health, OB nurse manager, and as an advanced practice nurse-midwife. She has 10+ years of experience teaching across an array of LPN, ADN, and BSN levels. Carmen received an Associate of Applied Science in Nuclear Medicine from Triton College, a Bachelor of Science in Nursing from the University of St. Francis, a Master of Science in Nursing from Case Western Reserve University, and a postgraduate certificate as an advanced practice nurse in nurse-midwifery at Frontier University.

  • Christopher Bojrab, MD - Advisory Board Member

    Christopher Bojrab, MD - Advisory Board Member

    Dr. Chris Bojrab is president of Indiana Health Group, the largest multidisciplinary behavioral health private practice in Indiana, established in 1987. He is a board certified psychiatrist and a Distinguished Fellow of the American Psychiatric Association who treats child, adolescent, adult, and geriatric patients. His areas of interest include psychopharmacology, mood and anxiety disorders, ADHD, sleep disorders, pain syndromes, and gambling addiction. After graduating from Wabash College, Dr. Bojrab received his M.D. degree from the Indiana University School of Medicine where he also completed his residency and served as chief resident. Dr. Bojrab is a past president of the Indiana Psychiatric Society and has served on the Board of Directors for Mental Health America of Indiana. He has also served as a delegate to the American Medical Association and as Indiana’s representative to the American Psychiatric Association for several years.

  • Dragan Primorac, MD, PhD - Advisory Board Member


    Prof. Dragan Primorac is a pediatrician, forensic expert and geneticist. He is the first recipient of the title “Global Penn State University Ambassador”. Currently he serves as President of International Society for Applied Biological Sciences, Chair of the International Affairs Committee of the American Academy of Forensic Sciences, President of the State Competitiveness Cluster in Personalized Medicine, President of The Croatian Society for Human Genetics, Director of World Academy of Pain Medicine Ultrasonography (Central European Chapter), and as a member of the International Consortium for Personalized Medicine Executive Committee (IC PerMEd) established by The European Commission. Dr. Primorac is a professor at Eberly College of Science, Pennsylvania State University; Henry C. Lee College of Criminal Justice and Forensic Sciences, University of New Haven; Medical Schools in Split, Osijek, and Rijeka, Croatia; and the Department of Biotechnology, University of Rijeka, in Croatia. From 2003 to 2009 he served as Minister of Science, Education and Sports of The Republic of Croatia.

  • Jeanette McCarthy, MPH, PhD - Advisory Board Member

    Jeanette McCarthy, MPH, PhD - Advisory Board Member

    As a genome scientist, Jeanette McCarthy, MPH, PhD spent years doing research on the genetic underpinnings of complex diseases, both infectious and chronic, and working to advance the field of precision medicine. More recently, Dr. McCarthy turned her attention to educating stakeholders in the field. She believes informed consumers will play a major role in their health care going forward. In 2014, Dr. McCarthy helped launch the first consumer-facing magazine in this field, Genome, where she was founding editor-in-chief. Dr. McCarthy has developed courses in precision medicine at UC Berkeley Extension and through UCSF via Coursera. She also designs and delivers workshops, symposia and webinars on more general, as well as technical topics, related to precision medicine through her consulting business, Precision Medicine Advisors and the Precision Medicine Foundation.

  • Julie Ceno-England, MD – Medical Advisor

    Julie Ceno-England, MD – Medical Advisor

    Dr. Julie England is a board-certified physician with over 15 years of clinical experience in Family Medicine. Dr. England’s interest is on health promotion using genomics to personalize individual health programs. Her company, Epigenetic Endeavors, advises clients on genomics, epigenetics and nutrigenomics to empower individuals to make proactive, research-based decisions about their overall health and wellness. Dr. England also serves as a medical director of an exercise and wellness studio in the Twin Cities. Julie received her B.A. in Biology from the University of Michigan and her M.D. from the American University of the Caribbean College of Medicine. She completed her residency training in Family Medicine at the University of Minnesota.

  • Paldeep S. Atwal, M.B., Ch.B. - Advisory Board Member

    Paldeep S. Atwal, M.B., Ch.B. - Advisory Board Member

    Dr. Atwal is a board-certified clinical and medical biochemical geneticist who formerly served at Mayo Clinic’s Jacksonville campus as medical director for the Center for Individualized Medicine and clinical lead for the Department of Clinical Genomics. He is a fellow of both The American College of Medical Genetics & Genomics and The Royal Colleges of Physicians of the United Kingdom. He received his medical degree from the University of Glasgow, Scotland and initially trained in hospital internal medicine with The Royal College of Physicians at Glasgow Royal Infirmary and various other hospitals around the Glasgow area. He completed his medical genetics residency at Stanford University Medical Center in Palo Alto, CA and his sub-specialty medical biochemical genetics fellowship at Baylor College of Medicine in Houston, TX. Additionally, he holds diplomas in Structural Molecular Biology and Forensic Medical Science.

  • Ross Higgins


    Ross joined OneOme in early 2016 to establish the company’s laboratory team and operational capabilities, successfully overseeing its CLIA certification, NY accreditation, and multiple CAP inspections. He now serves as an advisor to the company on matters of laboratory and scientific strategy. Before his involvement in OneOme, Ross led cross-functional product development and business development efforts at Douglas Scientific, a global leader of high-throughput genomic instrumentation in agricultural and clinical testing applications. In addition, Ross has previously held management and technical roles in other early stage and rapid-growth diagnostics/laboratory startup ventures. Ross has a B.S. in Clinical Laboratory Science and an M.B.A. from Virginia Commonwealth University. He also maintains ASCP certification as a Medical Laboratory Scientist.

  • Scott A. Storrer, MBA - Advisory Board Member

    Scott A. Storrer, MBA - Advisory Board Member

    Scott is responsible for the strategic development and expansion of the eHealth product line. A 25-year healthcare industry veteran, Scott brings deep, diverse and innovative experience in leading and growing healthcare businesses, having held senior management positions at Strand Life Sciences, a personalized medicine and biotechnology software solution provider and FirstLab, a third party administrator for substance abuse monitoring. Earlier in his career, Scott served as group president of Cardinal Health’s $81B pharmaceutical segment and executive vice president of Service and Technology for CIGNA.

  • Steven Tucker, MD, FACP, FAMS - Advisory Board Member

    Steven Tucker, MD, FACP, FAMS - Advisory Board Member

    While originally trained as a cancer specialist at the UCLA Center for Health Sciences, Dr. Tucker currently focuses on both adult general medicine and cancer medicine. Dr. Tucker is also an expert in medical technology and digital health. By studying information from multiple sources, such as personal genetics, metabolic testing, sensors and activity trackers, he helps patients develop personalized health plans that combine the elements of behavioral change with those of conventional medicine, as necessary. Dr. Tucker has received numerous honors and awards including a prestigious Merit Award from the American Society of Clinical Oncology and a Commendation from the U.S. National Institutes of Health. Dr. Tucker is a fellow of the American College of Physicians (FACP) and the Academy of Medicine, Singapore (FAMS), as well as an officer of the Chapter of Medical Oncologists, College of Physicians Singapore (CPS).

Team Toggle icon

Ben Metzger

Software Development


Bernard Esquivel, MD, MHA, PhD

Business Development

Esquivel, MD, MHA, PhD

Brett Miller

Business Development


Catie Pfeilsticker

Laboratory Operations


Chiara Aziz

Laboratory Operations


Colin Pistulka

Commercial Operations


Colleen Owen

Human Resources


Erica Schnettler

Medical Affairs


Erik Anderson



Hunter Kievet

Software Development


Jacob Sevlie

Software Development


Jake Comstock

Business Development


Jordan Gutzman



Karl Ruch

Medical Affairs


Kathleen Bosse

Clinical Development


Kirsten Bauer

Laboratory Operations


Kurt Wiersma

Software Development


Lilly Drew

Commercial Operations


Linda McDowell

Business Development


Lydia Kantor



Matt Hilden

Software Development


Megan Adelman

Clinical Development


Morgan Donaldson

Business Development


Steve Sheldon



Tyler Koep

Medical Affairs


Vaishnavi Soundararajan

Clinical Development


Vince Catania

Business Development


Wrenda Teeple

Clinical Development


Select partners

Ridgeview Medical

"Before OneOme, only those with deep financial resources or the critically ill could access the power of pharmacogenomics. Today, patients at Ridgeview can receive personalized prescription insights that previously were inaccessible to them. Not only will our patients see better health outcomes – they are also avoiding life-threatening adverse drug reactions, which are the fourth leading cause of death."

- Bob Stevens, President and CEO of Ridgeview Medical Center

ridgeview logo
tucker logo
medcan logo
doseme logo
personamed logo
rainbow logo
chemowave logo
Precision Med logo
St. Catherine logo